Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval

IQVIA
Sponsored Content

This webinar will provide an overview of the Japanese regulations and development in the Japanese market. Live: Thursday, Oct. 31, 2019 at 11am EDT On demand available after airing until Oct. 31, 2020 Register free

Register free: http://www.appliedclinicaltrialsonline.com/act_w/devices

Event Overview:
Approximately 10 years ago “Device Lag” was a major topic of discussion related to the Japanese regulatory environment. Currently, the Japanese government and the PMDA have improved their processes and “Device Lag” is no longer an issue. As a result, through good preparation it is now possible to launch medical devices in the Japanese market in a timely manner. You now have more control over how quickly your product is launched.

Japan has a universal health insurance system and the government determines reimbursement device and physician fees. Reimbursement will be based on the regulatory approval conditions; therefore, reimbursement strategy should be part of your overall business plan. Your goal should be receiving good reimbursement approval and a successful launch in the Japanese market and not simply regulatory approval.  

This webinar will provide an overview of the Japanese regulations and development in the Japanese market.     

Key Learning Objectives:

Overview of the Japanese:

Medical Device Market

Insurance System

Regulatory Environment

Speaker: Hiroshi Iwai, Regulatory Consultant, IQVIA Japan Group

Time and Date: Thursday, Oct. 31, 2019 at 11am EDT 

On demand available after airing until Oct. 31, 2020

Sponsor: IQVIA

Register free: http://www.appliedclinicaltrialsonline.com/act_w/devices